Home » Topics » Disease categories and therapies » Urology

Urology
RSS

Phase II trial data support efficacy of duloxetine in stress urinary incontinence

Sep. 21, 2001

Muscarinic receptor binding profile of YM-905 correlated with pharmacological activity

Sep. 20, 2001

Tiagabine as a potential treatment option for overactive bladder

Sep. 20, 2001

Human testing of injectable urethral bulking agent in progress

Sep. 20, 2001

Men with diabetes-related ED respond well to on-demand treatment with IC-351

Sep. 17, 2001

Interneuron initiates U.S. phase III clinical trial with trospium for overactive bladder

Sep. 13, 2001

Topiglan development continues to move forward

Sep. 12, 2001

BTG obtains rights to ANF peptide technology from Genentech

Sep. 10, 2001

Z-350 may reduce prostate growth without other hormonal effects

Sep. 7, 2001

Phase III results reported for Watson's transdermal oxybutynin patch

Sep. 6, 2001

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...